 MARIETTA, Ga., Sept. 07, 2021 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MIMEDX or the Company, an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will present at the H.C. Wainwright 23rd Annual Global Investment Conference held on September 13 - 15, 2021. 